# Ionetix and Atonco sign partnership for alpha radiopharmaceutical manufacturing

Ionetix and Atonco signed a partnership agreement for GMP manufacturing and supply of radiopharmaceuticals for Atonco's bladder cancer clinical studies and commercialization in the US.

- Type: Partnership
- Announced: 2022-03-31
- Where: Lansing, MI, United States
- Status: announced
- Products: alpha-emitting radiopharmaceuticals, astatine-211 radioisotope
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ionetix](https://endata.com/companies/61992.md) (partner)
- [Atonco](https://endata.com/companies/61993.md) (partner)

## Sources

- [atonco-pharma.com](https://atonco-pharma.com/en/2022/03/31/ionetix-atonco-sign-partnership-agreement-fight-bladder-cancer/), 2022-03-31: "We are very excited about the partnership with Atonco, which will allow us to actively collaborate in its clinical development program and commercialization in the United States."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.